Morgan B. Stern, Ph.D. - Publications

Affiliations: 
2014 Mathematics University of Maryland, College Park, College Park, MD 

229 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2021 Tropea TF, Amari N, Han N, Rick J, Suh E, Akhtar RS, Dahodwala N, Deik A, Gonzalez-Alegre P, Hurtig H, Siderowf A, Spindler M, Stern M, Thenganatt MA, Weintraub D, et al. Whole Clinic Research Enrollment in Parkinson's Disease: The Molecular Integration in Neurological Diagnosis (MIND) Study. Journal of Parkinson's Disease. PMID 33492247 DOI: 10.3233/JPD-202406  1
2020 Siderowf A, Jennings D, Stern M, Seibyl J, Eberly S, Oakes D, Marek K. Clinical and Imaging Progression in the PARS Cohort: Long-Term Follow-up. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 32657461 DOI: 10.1002/Mds.28139  1
2018 Berg D, Adler CH, Bloem BR, Chan P, Gasser T, Goetz CG, Halliday G, Lang AE, Lewis S, Li Y, Liepelt-Scarfone I, Litvan I, Marek K, Maetzler C, Mi T, ... ... Stern M, et al. Movement disorder society criteria for clinically established early Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 30145841 DOI: 10.1002/Mds.27431  1
2017 Chahine LM, Stern MB. Parkinson's Disease Biomarkers: Where Are We and Where Do We Go Next? Movement Disorders Clinical Practice. 4: 796-805. PMID 30363472 DOI: 10.1002/mdc3.12545  1
2017 Weintraub D, Chahine LM, Hawkins KA, Siderowf A, Eberly S, Oakes D, Seibyl J, Stern MB, Marek K, Jennings D. Cognition and the course of prodromal Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 29063713 DOI: 10.1002/Mds.27189  1
2017 Fullard ME, Xie SX, Marek K, Stern M, Jennings D, Siderowf A, Willis AW, Chen-Plotkin AS. Vitamin D in the Parkinson Associated Risk Syndrome (PARS) study. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 28906025 DOI: 10.1002/Mds.27127  1
2017 Jennings D, Siderowf A, Stern M, Seibyl J, Eberly S, Oakes D, Marek K. Conversion to Parkinson Disease in the PARS Hyposmic and Dopamine Transporter-Deficit Prodromal Cohort. Jama Neurology. PMID 28595287 DOI: 10.1001/Jamaneurol.2017.0985  1
2016 Postuma RB, Berg D, Stern M, Poewe W, Olanow CW, Oertel W, Marek K, Litvan I, Lang AE, Halliday G, Goetz CG, Gasser T, Dubois B, Chan P, Bloem BR, et al. Abolishing the 1-year rule: How much evidence will be enough? Movement Disorders : Official Journal of the Movement Disorder Society. PMID 27666574 DOI: 10.1002/Mds.26796  1
2016 Lim NS, Swanson CR, Cherng HR, Unger TL, Xie SX, Weintraub D, Marek K, Stern MB, Siderowf A, Trojanowski JQ, Chen-Plotkin AS. Plasma EGF and cognitive decline in Parkinson's disease and Alzheimer's disease. Annals of Clinical and Translational Neurology. 3: 346-55. PMID 27231704 DOI: 10.1002/Acn3.299  1
2016 Brennan L, Siderowf A, Rubright JD, Rick J, Dahodwala N, Duda JE, Hurtig H, Stern M, Xie SX, Rennert L, Karlawish J, Shea JA, Trojanowski JQ, Weintraub D. The Penn Parkinson's Daily Activities Questionnaire-15: Psychometric properties of a brief assessment of cognitive instrumental activities of daily living in Parkinson's disease. Parkinsonism & Related Disorders. PMID 26923524 DOI: 10.1016/J.Parkreldis.2016.02.020  1
2016 Postuma RB, Berg D, Adler CH, Bloem BR, Chan P, Deuschl G, Gasser T, Goetz CG, Halliday G, Joseph L, Lang AE, Liepelt-Scarfone I, Litvan I, Marek K, Oertel W, ... ... Stern M, et al. The new definition and diagnostic criteria of Parkinson's disease The Lancet Neurology. 15: 546-548. DOI: 10.1016/S1474-4422(16)00116-2  1
2015 Berg D, Postuma RB, Adler CH, Bloem BR, Chan P, Dubois B, Gasser T, Goetz CG, Halliday G, Joseph L, Lang AE, Liepelt-Scarfone I, Litvan I, Marek K, Obeso J, ... Stern M, et al. MDS research criteria for prodromal Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 30: 1600-11. PMID 26474317 DOI: 10.1002/Mds.26431  1
2015 Postuma RB, Berg D, Stern M, Poewe W, Olanow CW, Oertel W, Obeso J, Marek K, Litvan I, Lang AE, Halliday G, Goetz CG, Gasser T, Dubois B, Chan P, et al. MDS clinical diagnostic criteria for Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 30: 1591-601. PMID 26474316 DOI: 10.1002/Mds.26424  1
2015 Warren Olanow C, Bartus RT, Baumann TL, Factor S, Boulis N, Stacy M, Turner DA, Marks W, Larson P, Starr PA, Jankovic J, Simpson R, Watts R, Guthrie B, Poston K, ... Stern M, et al. Gene delivery of neurturin to putamen and substantia nigra in Parkinson disease: A double-blind, randomized, controlled trial. Annals of Neurology. 78: 248-57. PMID 26061140 DOI: 10.1002/Ana.24436  1
2015 Low PA, Reich SG, Jankovic J, Shults CW, Stern MB, Novak P, Tanner CM, Gilman S, Marshall FJ, Wooten F, Racette B, Chelimsky T, Singer W, Sletten DM, Sandroni P, et al. Natural history of multiple system atrophy in the USA: a prospective cohort study. The Lancet. Neurology. 14: 710-9. PMID 26025783 DOI: 10.1016/S1474-4422(15)00058-7  1
2015 Katz M, Luciano MS, Carlson K, Luo P, Marks WJ, Larson PS, Starr PA, Follett KA, Weaver FM, Stern MB, Reda DJ, Ostrem JL. Differential effects of deep brain stimulation target on motor subtypes in Parkinson's disease. Annals of Neurology. 77: 710-9. PMID 25627340 DOI: 10.1002/ana.24374  1
2015 Rothlind JC, York MK, Carlson K, Luo P, Marks WJ, Weaver FM, Stern M, Follett K, Reda D. Neuropsychological changes following deep brain stimulation surgery for Parkinson's disease: comparisons of treatment at pallidal and subthalamic targets versus best medical therapy. Journal of Neurology, Neurosurgery, and Psychiatry. 86: 622-9. PMID 25185211 DOI: 10.1136/Jnnp-2014-308119  1
2015 Chahine LM, Weintraub D, Hawkins KA, Siderowf A, Eberly S, Oakes D, Seibyl J, Stern MB, Marek K, Jennings D. Cognition in individuals at risk for Parkinson's: Parkinson associated risk syndrome (PARS) study findings Movement Disorders. DOI: 10.1002/mds.26373  1
2015 Brennan L, Siderowf A, Rubright JD, Rick J, Dahodwala N, Duda JE, Hurtig H, Stern M, Xie SX, Rennert L, Karlawish J, Shea JA, Trojanowski JQ, Weintraub D. Development and initial testing of the Penn Parkinson's Daily Activities Questionnaire Movement Disorders. DOI: 10.1002/mds.26339  1
2014 Jennings D, Siderowf A, Stern M, Seibyl J, Eberly S, Oakes D, Marek K. Imaging prodromal Parkinson disease: the Parkinson Associated Risk Syndrome Study. Neurology. 83: 1739-46. PMID 25298306 DOI: 10.1212/Wnl.0000000000000960  1
2014 Papay K, Xie SX, Stern M, Hurtig H, Siderowf A, Duda JE, Minger J, Weintraub D. Naltrexone for impulse control disorders in Parkinson disease: a placebo-controlled study. Neurology. 83: 826-33. PMID 25037206 DOI: 10.1212/Wnl.0000000000000729  1
2014 Berg D, Postuma RB, Bloem B, Chan P, Dubois B, Gasser T, Goetz CG, Halliday GM, Hardy J, Lang AE, Litvan I, Marek K, Obeso J, Oertel W, Olanow CW, ... Stern M, et al. Time to redefine PD? Introductory statement of the MDS Task Force on the definition of Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 29: 454-62. PMID 24619848 DOI: 10.1002/Mds.25844  1
2014 Chahine LM, Stern MB, Chen-Plotkin A. Blood-based biomarkers for Parkinson's disease. Parkinsonism & Related Disorders. 20: S99-103. PMID 24262199 DOI: 10.1016/S1353-8020(13)70025-7  1
2013 Fleisher JE, Stern MB. Medication nonadherence in Parkinson's disease. Current Neurology and Neuroscience Reports. 13: 382. PMID 23954970 DOI: 10.1007/s11910-013-0382-z  1
2013 Weintraub D, Duda JE, Carlson K, Luo P, Sagher O, Stern M, Follett KA, Reda D, Weaver FM. Suicide ideation and behaviours after STN and GPi DBS surgery for Parkinson's disease: results from a randomised, controlled trial. Journal of Neurology, Neurosurgery, and Psychiatry. 84: 1113-8. PMID 23667214 DOI: 10.1136/jnnp-2012-304396  1
2013 Berg D, Lang AE, Postuma RB, Maetzler W, Deuschl G, Gasser T, Siderowf A, Schapira AH, Oertel W, Obeso JA, Olanow CW, Poewe W, Stern M. Changing the research criteria for the diagnosis of Parkinson's disease: obstacles and opportunities. The Lancet. Neurology. 12: 514-24. PMID 23582175 DOI: 10.1016/S1474-4422(13)70047-4  1
2013 Gross RG, Camp E, McMillan CT, Dreyfuss M, Gunawardena D, Cook PA, Morgan B, Siderowf A, Hurtig HI, Stern MB, Grossman M. Impairment of script comprehension in Lewy body spectrum disorders. Brain and Language. 125: 330-43. PMID 23566691 DOI: 10.1016/J.Bandl.2013.02.006  1
2013 Qiang JK, Wong YC, Siderowf A, Hurtig HI, Xie SX, Lee VM, Trojanowski JQ, Yearout D, B Leverenz J, Montine TJ, Stern M, Mendick S, Jennings D, Zabetian C, Marek K, et al. Plasma apolipoprotein A1 as a biomarker for Parkinson disease. Annals of Neurology. 74: 119-27. PMID 23447138 DOI: 10.1002/Ana.23872  1
2013 Stern MB, Follett KA, Weaver FM. Randomized trial of deep brain stimulation for Parkinson disease: thirty-six-month outcomes; turning tables: should GPi become the preferred DBS target for Parkinson disease? Author response. Neurology. 80: 225. PMID 23424724 DOI: 10.1212/WNL.0b013e3182804657  1
2013 Adler CH, Stern MB. Redefining Parkinson's disease Parkinson's Disease: Diagnosis, Motor Symptoms and Non-Motor Features. 7-19. DOI: 10.2217/EBO.13.29  1
2012 Akhtar RS, Stern MB. New concepts in the early and preclinical detection of Parkinson's disease: therapeutic implications. Expert Review of Neurotherapeutics. 12: 1429-38. PMID 23237350 DOI: 10.1586/ern.12.144  1
2012 Weaver FM, Follett KA, Stern M, Luo P, Harris CL, Hur K, Marks WJ, Rothlind J, Sagher O, Moy C, Pahwa R, Burchiel K, Hogarth P, Lai EC, Duda JE, et al. Randomized trial of deep brain stimulation for Parkinson disease: thirty-six-month outcomes. Neurology. 79: 55-65. PMID 22722632 DOI: 10.1212/Wnl.0B013E31825Dcdc1  1
2012 Morley JF, Xie SX, Hurtig HI, Stern MB, Colcher A, Horn S, Dahodwala N, Duda JE, Weintraub D, Chen-Plotkin AS, Van Deerlin V, Falcone D, Siderowf A. Genetic influences on cognitive decline in Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 27: 512-8. PMID 22344634 DOI: 10.1002/Mds.24946  1
2012 Stern MB, Lang A, Poewe W. Toward a redefinition of Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 27: 54-60. PMID 22252891 DOI: 10.1002/mds.24051  1
2012 Siderowf A, Jennings D, Eberly S, Oakes D, Hawkins KA, Ascherio A, Stern MB, Marek K. Impaired olfaction and other prodromal features in the Parkinson At-Risk Syndrome Study. Movement Disorders : Official Journal of the Movement Disorder Society. 27: 406-12. PMID 22237833 DOI: 10.1002/Mds.24892  1
2012 Tolosa E, Stern MB. Efficacy, safety and tolerability of rasagiline as adjunctive therapy in elderly patients with Parkinson's disease. European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies. 19: 258-64. PMID 21819487 DOI: 10.1111/j.1468-1331.2011.03484.x  1
2012 Weaver FM, Follett KA, Stern M, Luo P, Harris CL, Hur K, Marks WJ, Rothlind J, Sagher O, Moy C, Pahwa R, Burchiel K, Hogarth P, Lai EC, Duda JE, et al. Randomized trial of deep brain stimulation for Parkinson's disease: 36 month outcomes (copy of NEUROLOGY/2011/402453, combining disclosures to single author only) Neurology. 99: 7-8. DOI: 10.1212/4  1
2011 Chahine LM, Stern MB. Rasagiline in Parkinson's disease. International Review of Neurobiology. 100: 151-68. PMID 21971007 DOI: 10.1016/B978-0-12-386467-3.00008-X  1
2011 Marek K, Jennings D, Lasch S, Siderowf A, Tanner C, Simuni T, Coffey C, Kieburtz K, Flagg E, Chowdhury S, Poewe W, Mollenhauer B, Sherer T, Frasier M, Meunier C, ... ... Stern M, et al. The Parkinson Progression Marker Initiative (PPMI) Progress in Neurobiology. 95: 629-635. PMID 21930184 DOI: 10.1016/J.Pneurobio.2011.09.005  1
2011 Kleiner-Fisman G, Martine R, Lang AE, Stern MB. Development of a non-motor fluctuation assessment instrument for Parkinson disease. Parkinson's Disease. 2011: 292719. PMID 21860778 DOI: 10.4061/2011/292719  1
2011 Rascol O, Lozano A, Stern M, Poewe W. Milestones in Parkinson's disease therapeutics. Movement Disorders : Official Journal of the Movement Disorder Society. 26: 1072-82. PMID 21626552 DOI: 10.1002/Mds.23714  1
2011 Chahine LM, Stern MB. Diagnostic markers for Parkinson's disease. Current Opinion in Neurology. 24: 309-17. PMID 21464716 DOI: 10.1097/WCO.0b013e3283461723  1
2011 Duda JE, Stern MB. Olfactory Dysfunction Parkinson's Disease: Non-Motor and Non-Dopaminergic Features. 304-314. DOI: 10.1002/9781444397970.ch28  1
2010 Marks WJ, Bartus RT, Siffert J, Davis CS, Lozano A, Boulis N, Vitek J, Stacy M, Turner D, Verhagen L, Bakay R, Watts R, Guthrie B, Jankovic J, Simpson R, ... ... Stern M, et al. Gene delivery of AAV2-neurturin for Parkinson's disease: a double-blind, randomised, controlled trial. The Lancet. Neurology. 9: 1164-72. PMID 20970382 DOI: 10.1016/S1474-4422(10)70254-4  1
2010 Kleiner-Fisman G, Stern MB, Fisman DN. Health-Related Quality of Life in Parkinson disease: Correlation between Health Utilities Index III and Unified Parkinson's Disease Rating Scale (UPDRS) in U.S. male veterans Health and Quality of Life Outcomes. 8. PMID 20799993 DOI: 10.1186/1477-7525-8-91  1
2010 Stern MB. Introductory remarks on the history and current applications of TCS International Review of Neurobiology. 90: 2-5. PMID 20692490 DOI: 10.1016/S0074-7742(10)90001-9  1
2010 Weintraub D, Mavandadi S, Mamikonyan E, Siderowf AD, Duda JE, Hurtig HI, Colcher A, Horn SS, Nazem S, Ten Have TR, Stern MB. Atomoxetine for depression and other neuropsychiatric symptoms in Parkinson disease. Neurology. 75: 448-55. PMID 20679638 DOI: 10.1212/Wnl.0B013E3181Ebdd79  1
2010 Stephenson R, Houghton D, Sundarararjan S, Doty RL, Stern M, Xie SX, Siderowf A. Odor identification deficits are associated with increased risk of neuropsychiatric complications in patients with Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 25: 2099-104. PMID 20669288 DOI: 10.1002/Mds.23234  1
2010 Rao H, Mamikonyan E, Detre JA, Siderowf AD, Stern MB, Potenza MN, Weintraub D. Decreased ventral striatal activity with impulse control disorders in Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 25: 1660-9. PMID 20589879 DOI: 10.1002/mds.23147  1
2010 Follett KA, Weaver FM, Stern M, Hur K, Harris CL, Luo P, Marks WJ, Rothlind J, Sagher O, Moy C, Pahwa R, Burchiel K, Hogarth P, Lai EC, Duda JE, et al. Pallidal versus subthalamic deep-brain stimulation for Parkinson's disease. The New England Journal of Medicine. 362: 2077-91. PMID 20519680 DOI: 10.1056/Nejmoa0907083  1
2010 Watts RL, Lyons KE, Pahwa R, Sethi K, Stern M, Hauser RA, Olanow W, Gray AM, Adams B, Earl NL. Onset of dyskinesia with adjunct ropinirole prolonged-release or additional levodopa in early Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 25: 858-66. PMID 20461803 DOI: 10.1002/mds.22890  1
2010 Stern MB, Siderowf A. Parkinson's at risk syndrome: Can Parkinson's disease be predicted? Movement Disorders. 25: S89-S93. PMID 20187248 DOI: 10.1002/mds.22719  1
2010 Kearns DA, Stern MB. Methods for high precision thermal conductivity measurements for electronics cooling Proceedings of the 30th International Thermal Conductivity Conference and the 18th International Thermal Expansion Symposium, Thermal Conductivity 30/Thermal Expansion 18. 552-562.  1
2009 Hoops S, Nazem S, Siderowf AD, Duda JE, Xie SX, Stern MB, Weintraub D. Validity of the MoCA and MMSE in the detection of MCI and dementia in Parkinson disease. Neurology. 73: 1738-45. PMID 19933974 DOI: 10.1212/Wnl.0B013E3181C34B47  1
2009 Stephenson R, Siderowf A, Stern MB. Premotor Parkinson's disease: clinical features and detection strategies. Movement Disorders : Official Journal of the Movement Disorder Society. 24: S665-70. PMID 19877244 DOI: 10.1002/mds.22403  1
2009 Mavandadi S, Nazem S, Ten Have TR, Siderowf AD, Duda JE, Stern MB, Weintraub D. Use of latent variable modeling to delineate psychiatric and cognitive profiles in Parkinson disease. The American Journal of Geriatric Psychiatry : Official Journal of the American Association For Geriatric Psychiatry. 17: 986-95. PMID 19855199 DOI: 10.1097/Jgp.0B013E3181B215Ec  1
2009 Olanow CW, Stern MB, Sethi K. The scientific and clinical basis for the treatment of Parkinson disease (2009) Neurology. 72: S1-S136. PMID 19470958 DOI: 10.1212/WNL.0b013e3181a1d44c  1
2009 Weintraub D, Hoops S, Shea JA, Lyons KE, Pahwa R, Driver-Dunckley ED, Adler CH, Potenza MN, Miyasaki J, Siderowf AD, Duda JE, Hurtig HI, Colcher A, Horn SS, Stern MB, et al. Validation of the questionnaire for impulsive-compulsive disorders in Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 24: 1461-7. PMID 19452562 DOI: 10.1002/mds.22571  1
2009 Dahodwala N, Siderowf A, Xie M, Noll E, Stern M, Mandell DS. Racial differences in the diagnosis of Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 24: 1200-5. PMID 19412929 DOI: 10.1002/mds.22557  1
2009 Phuong L, Garg S, Duda JE, Stern MB, Weintraub D. Involuntary emotional expression disorder (IEED) in Parkinson's disease Parkinsonism and Related Disorders. 15: 511-515. PMID 19181560 DOI: 10.1016/j.parkreldis.2009.01.001  1
2009 Nazem S, Siderowf AD, Duda JE, Have TT, Colcher A, Horn SS, Moberg PJ, Wilkinson JR, Hurtig HI, Stern MB, Weintraub D. Montreal cognitive assessment performance in patients with Parkinson's disease with "normal" global cognition according to mini-mental state examination score. Journal of the American Geriatrics Society. 57: 304-8. PMID 19170786 DOI: 10.1111/J.1532-5415.2008.02096.X  1
2009 Weaver FM, Follett K, Stern M, Hur K, Harris C, Marks WJ, Rothlind J, Sagher O, Reda D, Moy CS, Pahwa R, Burchiel K, Hogarth P, Lai EC, Duda JE, et al. Bilateral deep brain stimulation vs best medical therapy for patients with advanced Parkinson disease: a randomized controlled trial. Jama. 301: 63-73. PMID 19126811 DOI: 10.1001/Jama.2008.929  1
2009 Mamikonyan E, Moberg PJ, Siderowf A, Duda JE, Have TT, Hurtig HI, Stern MB, Weintraub D. Mild cognitive impairment is common in Parkinson's disease patients with normal Mini-Mental State Examination (MMSE) scores. Parkinsonism & Related Disorders. 15: 226-31. PMID 18595765 DOI: 10.1016/J.Parkreldis.2008.05.006  1
2009 Chaowasakoo T, Ng TH, Songninluck J, Stern MB, Ankireddi S. Indium solder as a thermal interface material using fluxless bonding technology Annual Ieee Semiconductor Thermal Measurement and Management Symposium. 180-185. DOI: 10.1109/STHERM.2009.4810761  1
2008 Siderowf A, Stern MB. Premotor Parkinson's disease: Clinical features, detection, and prospects for treatment Annals of Neurology. 64: S139-S147. PMID 19127581 DOI: 10.1002/ana.21462  1
2008 Olanow CW, Stern MB. Parkinson's disease: Unresolved issues Annals of Neurology. 64: S1-S2. PMID 19127574 DOI: 10.1002/ana.21501  1
2008 Goetz CG, Tilley BC, Shaftman SR, Stebbins GT, Fahn S, Martinez-Martin P, Poewe W, Sampaio C, Stern MB, Dodel R, Dubois B, Holloway R, Jankovic J, Kulisevsky J, Lang AE, et al. Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): scale presentation and clinimetric testing results. Movement Disorders : Official Journal of the Movement Disorder Society. 23: 2129-70. PMID 19025984 DOI: 10.1002/Mds.22340  1
2008 Nazem S, Siderowf AD, Duda JE, Brown GK, Ten Have T, Stern MB, Weintraub D. Suicidal and death ideation in Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 23: 1573-9. PMID 18618660 DOI: 10.1002/Mds.22130  1
2008 Oehlberg K, Barg FK, Brown GK, Taraborelli D, Stern MB, Weintraub D. Attitudes regarding the etiology and treatment of depression in Parkinson's disease: a qualitative study. Journal of Geriatric Psychiatry and Neurology. 21: 123-32. PMID 18474721 DOI: 10.1177/0891988708316862  1
2008 Stern MB. Transcranial ultrasound in Parkinson's disease The Lancet Neurology. 7: 376-378. PMID 18394966 DOI: 10.1016/S1474-4422(08)70068-1  1
2008 Mamikonyan E, Siderowf AD, Duda JE, Potenza MN, Horn S, Stern MB, Weintraub D. Long-term follow-up of impulse control disorders in Parkinson's disease Movement Disorders. 23: 75-80. PMID 17960796 DOI: 10.1002/mds.21770  1
2007 May S, Gilman S, Sowell BB, Thomas RG, Stern MB, Colcher A, Tanner CM, Huang N, Novak P, Reich SG, Jankovic J, Ondo WG, Low PA, Sandroni P, Lipp A, et al. Potential outcome measures and trial design issues for multiple system atrophy. Movement Disorders : Official Journal of the Movement Disorder Society. 22: 2371-7. PMID 17914727 DOI: 10.1002/Mds.21734  1
2007 Siderowf A, Jennings D, Connolly J, Doty RL, Marek K, Stern MB. Risk factors for Parkinson's disease and impaired olfaction in relatives of patients with Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 22: 2249-55. PMID 17876851 DOI: 10.1002/mds.21707  1
2007 Moberg PJ, Balderston CC, Rick JH, Roalf DR, Weintraub D, Kleiner-Fisman G, Stern MB, Duda JE. Phenylthiocarbamide (PTC) perception in Parkinson disease. Cognitive and Behavioral Neurology : Official Journal of the Society For Behavioral and Cognitive Neurology. 20: 145-8. PMID 17846512 DOI: 10.1097/WNN.0b013e31812570c3  1
2007 Dennison AC, Noorigian JV, Robinson KM, Fisman DN, Cianci HJ, Moberg P, Bunting-Perry L, Martine R, Duda J, Stern MB. Falling in Parkinson disease: identifying and prioritizing risk factors in recurrent fallers. American Journal of Physical Medicine & Rehabilitation / Association of Academic Physiatrists. 86: 621-32. PMID 17667192 DOI: 10.1097/PHM.0b013e311611583  1
2007 Kleiner-Fisman G, Liang GS, Moberg PJ, Ruocco AC, Hurtig HI, Baltuch GH, Jaggi JL, Stern MB. Subthalamic nucleus deep brain stimulation for severe idiopathic dystonia: impact on severity, neuropsychological status, and quality of life. Journal of Neurosurgery. 107: 29-36. PMID 17639870 DOI: 10.3171/Jns-07/07/0029  1
2007 Weintraub D, Stern MB. Intervening in the neuropsychiatric features of Parkinson's disease Expert Review of Neurotherapeutics. 7: 699-710. PMID 17563252 DOI: 10.1586/14737175.7.6.699  1
2007 Weintraub D, Saboe K, Stern MB. Effect of age on geriatric depression scale performance in Parkinson's disease Movement Disorders. 22: 1331-1335. PMID 17546674 DOI: 10.1002/mds.21369  1
2007 Dahodwala N, Connolly J, Farmer J, Stern MB, Jennings D, Siderowf A. Interest in predictive testing for Parkinson's disease: impact of neuroprotective therapy. Parkinsonism & Related Disorders. 13: 495-9. PMID 17449316 DOI: 10.1016/j.parkreldis.2007.02.010  1
2007 Lew MF, Pahwa R, Leehey M, Bertoni J, Kricorian G, Avin BH, Calabrese V, Factor S, Fazzini EA, Hauser RA, Hubble JP, Hutton JT, Jacoby RG, Kelly J, Kirby LC, ... ... Stern MB, et al. Safety and efficacy of newly formulated selegiline orally disintegrating tablets as an adjunct to levodopa in the management of 'off' episodes in patients with Parkinson's disease Current Medical Research and Opinion. 23: 741-750. PMID 17407630 DOI: 10.1185/030079906X167697  1
2007 Prasad S, Ko MW, Lee EB, Gonatas NK, Stern MB, Galetta S. Supranuclear vertical gaze abnormalities in sporadic Creutzfeldt-Jakob disease. Journal of the Neurological Sciences. 253: 69-72. PMID 17234215 DOI: 10.1016/J.Jns.2006.11.010  1
2007 Ozelius LJ, Foroud T, May S, Senthil G, Sandroni P, Low PA, Reich S, Colcher A, Stern MB, Ondo WG, Jankovic J, Huang N, Tanner CM, Novak P, Gilman S, et al. G2019S mutation in the leucine-rich repeat kinase 2 gene is not associated with multiple system atrophy. Movement Disorders : Official Journal of the Movement Disorder Society. 22: 546-9. PMID 17230458 DOI: 10.1002/Mds.21343  1
2007 Goetz CG, Fahn S, Martinez-Martin P, Poewe W, Sampaio C, Stebbins GT, Stern MB, Tilley BC, Dodel R, Dubois B, Holloway R, Jankovic J, Kulisevsky J, Lang AE, Lees A, et al. Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): Process, format, and clinimetric testing plan. Movement Disorders : Official Journal of the Movement Disorder Society. 22: 41-7. PMID 17115387 DOI: 10.1002/mds.21198  1
2007 Olevsky EA, Wang X, Ma J, Maximenko A, Stern MB. Sequential deposition and electroforming of metal-ceramic composites for thermal management applications Surface Engineering. 23: 12-17. DOI: 10.1179/174329407X161654  1
2007 Weintraub D, Stern MB. Disorders of mood and affect in Parkinson's disease Handbook of Clinical Neurology. 83: 421-433. DOI: 10.1016/S0072-9752(07)83019-3  1
2007 Olevsky EA, Wang X, Bruce E, Stern MB, Wildhack S, Aldinger F. Synthesis of gold micro- and nano-wires by infiltration and thermolysis Scripta Materialia. 56: 867-869. DOI: 10.1016/j.scriptamat.2007.01.037  1
2006 Liang GS, Chou KL, Baltuch GH, Jaggi JL, Loveland-Jones C, Leng L, Maccarone H, Hurtig HI, Colcher A, Stern MB, Kleiner-Fisman G, Simuni T, Siderowf AD. Long-term outcomes of bilateral subthalamic nucleus stimulation in patients with advanced Parkinson's disease Stereotactic and Functional Neurosurgery. 84: 221-227. PMID 17063043 DOI: 10.1159/000096495  1
2006 Weaver FM, Stern MB, Follett K. Deep-brain stimulation in Parkinson's disease Lancet Neurology. 5: 900-901. PMID 17052655 DOI: 10.1016/S1474-4422(06)70586-5  1
2006 Weintraub D, Taraborelli D, Morales KH, Duda JE, Katz IR, Stern MB. Escitalopram for major depression in Parkinson's disease: an open-label, flexible-dosage study. The Journal of Neuropsychiatry and Clinical Neurosciences. 18: 377-83. PMID 16963587 DOI: 10.1176/appi.neuropsych.18.3.377  1
2006 deMarcaida JA, Schwid SR, White WB, Blindauer K, Fahn S, Kieburtz K, Stern M, Shoulson I. Effects of tyramine administration in Parkinson's disease patients treated with selective MAO-B inhibitor rasagiline. Movement Disorders : Official Journal of the Movement Disorder Society. 21: 1716-21. PMID 16856145 DOI: 10.1002/Mds.21048  1
2006 Weintraub D, Siderowf AD, Potenza MN, Goveas J, Morales KH, Duda JE, Moberg PJ, Stern MB. Association of dopamine agonist use with impulse control disorders in Parkinson disease. Archives of Neurology. 63: 969-73. PMID 16831966 DOI: 10.1001/Archneur.63.7.969  1
2006 Siderowf A, Stern MB. Preclinical diagnosis of Parkinson's disease: Are we there yet? Current Neurology and Neuroscience Reports. 6: 295-301. PMID 16822349 DOI: 10.1007/s11910-006-0021-z  1
2006 Weintraub D, Morales KH, Duda JE, Moberg PJ, Stern MB. Frequency and correlates of co-morbid psychosis and depression in Parkinson's disease. Parkinsonism & Related Disorders. 12: 427-31. PMID 16797214 DOI: 10.1016/j.parkreldis.2006.03.006  1
2006 Blindauer K, Shoulson I, Oakes D, Kieburtz K, Schwid S, Fahn S, Stern M, Goetz C, Nutt J, Goren S, Sayag N, Scolnik M, Levy R, Eyal E, Salzman P, et al. A randomized controlled trial of etilevodopa in patients with Parkinson disease who have motor fluctuations. Archives of Neurology. 63: 210-6. PMID 16476809 DOI: 10.1001/Archneur.63.2.210  1
2006 Weintraub D, Oehlberg KA, Katz IR, Stern MB. Test characteristics of the 15-item geriatric depression scale and Hamilton depression rating scale in Parkinson disease. The American Journal of Geriatric Psychiatry : Official Journal of the American Association For Geriatric Psychiatry. 14: 169-75. PMID 16473982 DOI: 10.1097/01.JGP.0000192488.66049.4b  1
2006 Weintraub D, Cary MS, Stern MB, Taraborelli D, Katz IR. Daily affect in Parkinson disease is responsive to life events and motor symptoms. The American Journal of Geriatric Psychiatry : Official Journal of the American Association For Geriatric Psychiatry. 14: 161-8. PMID 16473981 DOI: 10.1097/01.JGP.0000192494.96543.f4  1
2006 Siderowf A, Jaggi JL, Xie SX, Loveland-Jones C, Leng L, Hurtig H, Colcher A, Stern M, Chou KL, Liang G, Maccarone H, Simuni T, Baltuch G. Long-term effects of bilateral subthalamic nucleus stimulation on health-related quality of life in advanced Parkinson's disease. Movement Disorders. 21: 746-753. PMID 16463342 DOI: 10.1002/Mds.20786  1
2006 Liang TW, Truax AC, Trojanowski JQ, Lee VM, Stern MB, Kotzbauer PT. Partial deficit of pantothenate kinase 2 catalytic activity in a case of tremor-predominant neurodegeneration with brain iron accumulation. Movement Disorders : Official Journal of the Movement Disorder Society. 21: 718-22. PMID 16450344 DOI: 10.1002/Mds.20797  1
2006 Biglan KM, Schwid S, Eberly S, Blindauer K, Fahn S, Goren T, Kieburtz K, Oakes D, Plumb S, Siderowf A, Stern M, Shoulson I. Rasagiline improves quality of life in patients with early Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 21: 616-23. PMID 16450340 DOI: 10.1002/Mds.20764  1
2006 Caroff SN, Martine R, Kleiner-Fisman G, Eisa M, Lorry A, Gallop R, Stern MB, Duda JE. Treatment of levodopa-induced dyskinesias with donepezil Parkinsonism and Related Disorders. 12: 261-263. PMID 16364675 DOI: 10.1016/J.Parkreldis.2005.10.003  1
2006 Stern MB, Jhoty G, Kearns D, Ong B. Measurements of mechanical coupling of non-curing high performance thermal interface materials Annual Ieee Semiconductor Thermal Measurement and Management Symposium. 2006: 37-41.  1
2005 Robinson K, Dennison A, Roalf D, Noorigian J, Cianci H, Bunting-Perry L, Moberg P, Kleiner-Fisman G, Martine R, Duda J, Jaggi J, Stern M. Falling risk factors in Parkinson's disease Neurorehabilitation. 20: 169-182. PMID 16340098 DOI: 10.3233/Nre-2005-20304  1
2005 Weintraub D, Stern MB. Psychiatric complications in Parkinson disease American Journal of Geriatric Psychiatry. 13: 844-851. PMID 16223962 DOI: 10.1097/00019442-200510000-00003  1
2005 Follett K, Weaver F, Stern M, Marks W, Hogarth P, Holloway K, Bronstein J, Duda J, Horn S, Lai E, Samii A, Okun MS, Foote KD. Multisite randomized trial of deep brain stimulation [4] (multiple letters) Archives of Neurology. 62: 1643-1645. PMID 16216957 DOI: 10.1001/archneur.62.10.1643-b  1
2005 Clement PD, Keisler PD, Kneedler ES, Katsas GG, Hallward-Driemeier D, Stern MB, Levy JH. Brief for the petitioners. Gonzales v. State of Oregon Issues in Law & Medicine. 21: 59-75. PMID 16173505  1
2005 Weintraub D, Moberg PJ, Culbertson WC, Duda JE, Katz IR, Stern MB. Dimensions of executive function in Parkinson's disease. Dementia and Geriatric Cognitive Disorders. 20: 140-4. PMID 16020942 DOI: 10.1159/000087043  1
2005 Weintraub D, Morales KH, Moberg PJ, Bilker WB, Balderston C, Duda JE, Katz IR, Stern MB. Antidepressant studies in Parkinson's disease: a review and meta-analysis. Movement Disorders : Official Journal of the Movement Disorder Society. 20: 1161-9. PMID 15954137 DOI: 10.1002/Mds.20555  1
2005 Siderowf A, Newberg A, Chou KL, Lloyd M, Colcher A, Hurtig HI, Stern MB, Doty RL, Mozley PD, Wintering N, Duda JE, Weintraub D, Moberg PJ. [99mTc]TRODAT-1 SPECT imaging correlates with odor identification in early Parkinson disease. Neurology. 64: 1716-20. PMID 15911797 DOI: 10.1212/01.WNL.0000161874.52302.5D  1
2005 Weintraub D, Newberg AB, Cary MS, Siderowf AD, Moberg PJ, Kleiner-Fisman G, Duda JE, Stern MB, Mozley D, Katz IR. Striatal dopamine transporter imaging correlates with anxiety and depression symptoms in Parkinson's disease. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 46: 227-32. PMID 15695780  1
2005 Wang X, Ma J, Maximenko A, Olevsky EA, Stern MB, Guenin BM. Sequential deposition of copper/alumina composites Journal of Materials Science. 40: 4963-4965. DOI: 10.1007/S10853-005-2704-2  1
2005 Linares LO, Rosbruch N, Stern MB, Edwards ME, Walker G, Abikoff HB, Alvir JMJ. Developing cognitive-social-emotional competencies to enhance academic learning Psychology in the Schools. 42: 405-417. DOI: 10.1002/Pits.20066  1
2005 Stern MB, Gektin V, Pecavar S, Kearns D, Chen T. Evaluation of high performance thermal greases for CPU package cooling applications Annual Ieee Semiconductor Thermal Measurement and Management Symposium. 39-43.  1
2004 Weintraub D, Moberg PJ, Culbertson WC, Duda JE, Stern MB. Evidence for impaired encoding and retrieval memory profiles in Parkinson disease. Cognitive and Behavioral Neurology : Official Journal of the Society For Behavioral and Cognitive Neurology. 17: 195-200. PMID 15622014  1
2004 Stern MB. Dopamine agonists modify the course of Parkinson disease Archives of Neurology. 61: 1969-1971. PMID 15596624 DOI: 10.1001/archneur.61.12.1969  1
2004 Horn S, Stern MB. The comparative effects of medical therapies for Parkinson's disease Neurology. 63: S7-S12. PMID 15477585  1
2004 Jaggi JL, Umemura A, Hurtig HI, Siderowf AD, Colcher A, Stern MB, Baltuch GH. Bilateral stimulation of the subthalamic nucleus in Parkinson's disease: Surgical efficacy and prediction of outcome Stereotactic and Functional Neurosurgery. 82: 104-114. PMID 15305083 DOI: 10.1159/000078145  1
2004 Stern MB, Marek KL, Friedman J, Hauser RA, LeWitt PA, Tarsy D, Olanow CW. Double-blind, randomized, controlled trial of rasagiline as monotherapy in early Parkinson's disease patients Movement Disorders. 19: 916-923. PMID 15300656 DOI: 10.1002/mds.20145  1
2004 Stern MB. The preclinical detection of Parkinson's disease: Ready for prime time? Annals of Neurology. 56: 169-171. PMID 15293267 DOI: 10.1002/ana.20180  1
2004 Chou KL, Hurtig HI, Stern MB, Colcher A, Ravina B, Newberg A, Mozley PD, Siderowf A. Diagnostic accuracy of [99mTc]TRODAT-1 SPECT imaging in early Parkinson's disease Parkinsonism and Related Disorders. 10: 375-379. PMID 15261880 DOI: 10.1016/j.parkreldis.2004.04.002  1
2004 Li YJ, Hauser MA, Scott WK, Martin ER, Booze MW, Qin XJ, Walter JW, Nance MA, Hubble JP, Koller WC, Pahwa R, Stern MB, Hiner BC, Jankovic J, Goetz CG, et al. Apolipoprotein E controls the risk and age at onset of Parkinson disease. Neurology. 62: 2005-9. PMID 15184605 DOI: 10.1212/01.Wnl.0000128089.53030.Ac  1
2004 Weintraub D, Moberg PJ, Duda JE, Katz IR, Stern MB. Effect of psychiatric and other nonmotor symptoms on disability in Parkinson's disease. Journal of the American Geriatrics Society. 52: 784-8. PMID 15086662 DOI: 10.1111/J.1532-5415.2004.52219.X  1
2004 Umemura A, Jaggi JL, Dolinskas CA, Stern MB, Baltuch GH. Pallidal deep brain stimulation for longstanding severe generalized dystonia in Hallervorden-Spatz syndrome: Case report Journal of Neurosurgery. 100: 706-709. PMID 15070127  1
2004 Culbertson WC, Moberg PJ, Duda JE, Stern MB, Weintraub D. Assessing the executive function deficits of patients with Parkinson's disease: utility of the Tower of London-Drexel. Assessment. 11: 27-39. PMID 14994951 DOI: 10.1177/1073191103258590  1
2004 Koller WC, Stern MB, Watts R. The evolving role of monoamine oxidase inhibitors in the treatment of Parkinson's disease Neurology. 63: S1.  1
2003 Roth T, Rye DB, Borchert LD, Bartlett C, Bliwise DL, Cantor C, Gorell JM, Hubble JP, Musch B, Olanow CW, Pollak C, Stern MB, Watts RL. Assessment of sleepiness and unintended sleep in Parkinson's disease patients taking dopamine agonists. Sleep Medicine. 4: 275-80. PMID 14592299 DOI: 10.1016/S1389-9457(03)00058-3  1
2003 Li YJ, Oliveira SA, Xu P, Martin ER, Stenger JE, Scherzer CR, Hauser MA, Scott WK, Small GW, Nance MA, Watts RL, Hubble JP, Koller WC, Pahwa R, Stern MB, et al. Glutathione S-transferase omega-1 modifies age-at-onset of Alzheimer disease and Parkinson disease. Human Molecular Genetics. 12: 3259-67. PMID 14570706 DOI: 10.1093/Hmg/Ddg357  1
2003 Weintraub D, Moberg PJ, Duda JE, Katz IR, Stern MB. Recognition and treatment of depression in Parkinson's disease. Journal of Geriatric Psychiatry and Neurology. 16: 178-83. PMID 12967062 DOI: 10.1177/0891988703256053  1
2003 Oliveira SA, Scott WK, Nance MA, Watts RL, Hubble JP, Koller WC, Lyons KE, Pahwa R, Stern MB, Hiner BC, Jankovic J, Ondo WG, Allen FH, Scott BL, Goetz CG, et al. Association study of Parkin gene polymorphisms with idiopathic Parkinson disease. Archives of Neurology. 60: 975-80. PMID 12873854 DOI: 10.1001/Archneur.60.7.975  1
2003 Lee C, Grossman M, Morris J, Stern MB, Hurtig HI. Attentional resource and processing speed limitations during sentence processing in Parkinson's disease Brain and Language. 85: 347-356. PMID 12744946 DOI: 10.1016/S0093-934X(03)00063-4  1
2003 Lyons KE, Pahwa R, Comella CL, Eisa MS, Elble RJ, Fahn S, Jankovic J, Juncos JL, Koller WC, Ondo WG, Sethi KD, Stern MB, Tanner CM, Tintner R, Watts RL. Benefits and risks of pharmacological treatments for essential tremor. Drug Safety. 26: 461-81. PMID 12735785 DOI: 10.2165/00002018-200326070-00003  1
2003 Oliveira SA, Scott WK, Martin ER, Nance MA, Watts RL, Hubble JP, Koller WC, Pahwa R, Stern MB, Hiner BC, Ondo WG, Allen FH, Scott BL, Goetz CG, Small GW, et al. Parkin mutations and susceptibility alleles in late-onset Parkinson's disease. Annals of Neurology. 53: 624-9. PMID 12730996 DOI: 10.1002/Ana.10524  1
2003 Umemura A, Jaggi JL, Hurtig HI, Siderowf AD, Colcher A, Stern MB, Baltuch GH. Deep brain stimulation for movement disorders: Morbidity and mortality in 109 patients Journal of Neurosurgery. 98: 779-784. PMID 12691402  1
2003 van der Walt JM, Martin ER, Scott WK, Zhang F, Nance MA, Watts RL, Hubble JP, Haines JL, Koller WC, Lyons K, Pahwa R, Stern MB, Colcher A, Hiner BC, Jankovic J, et al. Genetic polymorphisms of the N-acetyltransferase genes and risk of Parkinson's disease. Neurology. 60: 1189-91. PMID 12682333 DOI: 10.1212/01.Wnl.0000055929.84668.9A  1
2003 Grossman M, Cooke A, DeVita C, Lee C, Alsop D, Detre J, Gee J, Chen W, Stern MB, Hurtig HI. Grammatical and resource components of sentence processing in Parkinson's disease: an fMRI study. Neurology. 60: 775-81. PMID 12629232 DOI: 10.1212/01.WNL.0000044398.73241.13  1
2003 van der Walt JM, Nicodemus KK, Martin ER, Scott WK, Nance MA, Watts RL, Hubble JP, Haines JL, Koller WC, Lyons K, Pahwa R, Stern MB, Colcher A, Hiner BC, Jankovic J, et al. Mitochondrial polymorphisms significantly reduce the risk of Parkinson disease. American Journal of Human Genetics. 72: 804-11. PMID 12618962 DOI: 10.1086/373937  1
2002 Siderowf A, Stern M, Shoulson I, Kieburtz K, Oakes D, Day D, Shinaman A, Plumb S, Fahn S, Blindauer K, Lew M, Hurtig H, Lloyd M, Hauser R, Gauger L, et al. A controlled trial of rasagiline in early Parkinson disease: The tempo study Archives of Neurology. 59: 1937-1943. PMID 12470183 DOI: 10.1001/Archneur.59.12.1937  1
2002 Shults CW, Oakes D, Kieburtz K, Beal MF, Haas R, Plumb S, Juncos JL, Nutt J, Shoulson I, Carter J, Kompoliti K, Perlmutter JS, Reich S, Stern M, Watts RL, et al. Effects of coenzyme Q10 in early Parkinson disease: evidence of slowing of the functional decline. Archives of Neurology. 59: 1541-50. PMID 12374491 DOI: 10.1001/Archneur.59.10.1541  1
2002 Simuni T, Jaggi JL, Mulholland H, Hurtig HI, Colcher A, Siderowf AD, Ravina B, Skolnick BE, Goldstein R, Stern MB, Baltuch GH. Bilateral stimulation of the subthalamic nucleus in patients with Parkinson disease: A study of efficacy and safety Journal of Neurosurgery. 96: 666-672. PMID 11990805  1
2002 Grossman M, Zurif E, Lee C, Prather P, Kalmanson J, Stern MB, Hurtig HI. Information processing speed and sentence comprehension in Parkinson's disease. Neuropsychology. 16: 174-81. PMID 11949709 DOI: 10.1037//0894-4105.16.2.174  1
2002 Cantor CR, Stern MB. Dopamine agonists and sleep in Parkinson's disease. Neurology. 58: S71-8. PMID 11909988  1
2002 Grossman M, Lee C, Morris J, Stern MB, Hurtig HI. Assessing resource demands during sentence processing in Parkinson's disease Brain and Language. 80: 603-616. PMID 11896660 DOI: 10.1006/brln.2001.2630  1
2002 Li YJ, Scott WK, Hedges DJ, Zhang F, Gaskell PC, Nance MA, Watts RL, Hubble JP, Koller WC, Pahwa R, Stern MB, Hiner BC, Jankovic J, Allen FA, Goetz CG, et al. Age at onset in two common neurodegenerative diseases is genetically controlled. American Journal of Human Genetics. 70: 985-93. PMID 11875758 DOI: 10.1086/339815  1
2001 Siderowf A, Gollump SM, Stern MB, Baltuch GH, Riina HA. Emergence of complex, involuntary movements after gamma knife radiosurgery for essential tremor Movement Disorders. 16: 965-967. PMID 11746633 DOI: 10.1002/mds.1178  1
2001 Martin ER, Scott WK, Nance MA, Watts RL, Hubble JP, Koller WC, Lyons K, Pahwa R, Stern MB, Colcher A, Hiner BC, Jankovic J, Ondo WG, Allen FH, Goetz CG, et al. Association of single-nucleotide polymorphisms of the tau gene with late-onset Parkinson disease. Jama. 286: 2245-50. PMID 11710889 DOI: 10.1001/Jama.286.18.2245  1
2001 Scott WK, Nance MA, Watts RL, Hubble JP, Koller WC, Lyons K, Pahwa R, Stern MB, Colcher A, Hiner BC, Jankovic J, Ondo WG, Allen FH, Goetz CG, Small GW, et al. Complete genomic screen in Parkinson disease: evidence for multiple genes. Jama. 286: 2239-44. PMID 11710888 DOI: 10.1001/Jama.286.18.2239  1
2001 During MJ, Kaplitt MG, Stern MB, Eidelberg D. Subthalamic GAD gene transfer in Parkinson disease patients who are candidates for deep brain stimulation. Human Gene Therapy. 12: 1589-91. PMID 11529246  1
2001 Grossman M, Glosser G, Kalmanson J, Morris J, Stern MB, Hurtig HI. Dopamine supports sentence comprehension in Parkinson's Disease. Journal of the Neurological Sciences. 184: 123-30. PMID 11239945 DOI: 10.1016/S0022-510X(00)00491-3  1
2001 Hurtig HI, Stern MB. Neurologic clinics: Foreword Neurologic Clinics. 19: xiii. DOI: 10.1016/S0733-8619(05)70031-1  1
2001 Hurtig HI, Stern MB. The patient centered approach to movement disorders Neurologic Clinics. 19: xi-xii. DOI: 10.1016/S0733-8619(05)70030-X  1
2000 Duda JE, Giasson BI, Chen Q, Gur TL, Hurtig HI, Stern MB, Gollomp SM, Ischiropoulos H, Lee VM, Trojanowski JQ. Widespread nitration of pathological inclusions in neurodegenerative synucleinopathies. The American Journal of Pathology. 157: 1439-45. PMID 11073803 DOI: 10.1016/S0002-9440(10)64781-5  1
2000 Duda JE, Giasson BI, Gur TL, Montine TJ, Robertson D, Biaggioni I, Hurtig HI, Stern MB, Gollomp SM, Grossman M, Lee VM, Trojanowski JQ. Immunohistochemical and biochemical studies demonstrate a distinct profile of alpha-synuclein permutations in multiple system atrophy. Journal of Neuropathology and Experimental Neurology. 59: 830-41. PMID 11005264 DOI: 10.1093/Jnen/59.9.830  1
2000 Boockvar JA, Telfeian A, Baltuch GH, Skolnick B, Simuni T, Stern M, Schmidt ML, Trojanowski JQ. Long-term deep brain stimulation in a patient with essential tremor: Clinical response and postmortem correlation with stimulator termination sites in ventral thalamus. Case report Journal of Neurosurgery. 93: 140-144. PMID 10883919 DOI: 10.3171/Jns.2000.93.1.0140  1
2000 Grossman M, Kalmanson J, Bernhardt N, Morris J, Stern MB, Hurtig HI. Cognitive resource limitations during sentence comprehension in Parkinson's disease. Brain and Language. 73: 1-16. PMID 10872635 DOI: 10.1006/brln.2000.2290  1
2000 Alterman RL, Reiter GT, Shils J, Skolnick B, Arle JE, Lesutis M, Simuni T, Colcher A, Stern M, Hurtig H. Targeting for thalamic deep brain stimulator implantation without computer guidance: Assessment of targeting accuracy Stereotactic and Functional Neurosurgery. 72: 150-153. PMID 10853070 DOI: 10.1159/000029718  1
2000 Siderowf AD, Holloway RG, Stern MB. Cost-effectiveness analysis in Parkinson's disease: Determining the value of interventions Movement Disorders. 15: 439-445. PMID 10830407 DOI: 10.1002/1531-8257(200005)15:3<439::AID-MDS1004>3.0.CO;2-F  1
2000 Hurtig HI, Trojanowski JQ, Galvin J, Ewbank D, Schmidt ML, Lee VM, Clark CM, Glosser G, Stern MB, Gollomp SM, Arnold SE. Alpha-synuclein cortical Lewy bodies correlate with dementia in Parkinson's disease. Neurology. 54: 1916-21. PMID 10822429 DOI: 10.1212/Wnl.54.10.1916  1
2000 Mozley PD, Schneider JS, Acton PD, Plössl K, Stern MB, Siderowf A, Leopold NA, Li PY, Alavi A, Kung HF. Binding of [99mTc]TRODAT-1 to dopamine transporters in patients with Parkinson's disease and in healthy volunteers Journal of Nuclear Medicine. 41: 584-589. PMID 10768556  1
2000 Stern MB. The early treatment of Parkinson's disease: Levodopa, dopamine agonists or both Parkinsonism and Related Disorders. 7: 27-33. DOI: 10.1016/S1353-8020(00)00045-6  1
2000 Stern MB, Klein AB. The government's litigator: Taking clients seriously Administrative Law Review. 52: 1409.  1
1999 Scott WK, Yamaoka LH, Stajich JM, Scott BL, Vance JM, Roses AD, Pericak-Vance MA, Watts RL, Nance M, Hubble J, Koller W, Stern MB, Colcher A, Allen FH, Hiner BC, et al. The alpha-synuclein gene is not a major risk factor in familial Parkinson disease. Neurogenetics. 2: 191-2. PMID 10541595 DOI: 10.1007/S100480050083  1
1999 Simuni T, Stern MB. Does levodopa accelerate Parkinson's disease? Drugs and Aging. 14: 399-408. PMID 10408739 DOI: 10.2165/00002512-199914060-00001  1
1999 Stern MB, Hurtig HI. Medical Clinics of North America: Preface Medical Clinics of North America. 83: xi-xii. DOI: 10.1016/S0025-7125(05)70106-1  1
1999 Colcher A, Stern MB. Therapeutics in the neurorehabilitation of Parkinson's disease Neurorehabilitation and Neural Repair. 13: 205-218.  1
1999 Simuni T, Stern MB. Parkinson's disease: Seven questions physicians often ask Consultant. 39: 367-381.  1
1998 Walker CK, Hungerford AL, Narayanan G, Groppi CE, Bloomstein TM, Palmacci ST, Stern MB, Curtin JE. Laser micromachining of silicon: A new technique for fabricating terahertz imaging arrays Proceedings of Spie - the International Society For Optical Engineering. 3357: 45-52. DOI: 10.1117/12.317377  1
1998 Palmateer SC, Cann SG, Curtin JE, Doran SP, Eriksen LM, Forte AR, Kunz RR, Lyszczarz TM, Stern MB, Nelson-Thomas CM. Line-edge roughness in sub-0.18-μm resist patterns Proceedings of Spie - the International Society For Optical Engineering. 3333: 634-642. DOI: 10.1117/12.312395  1
1998 Simuni T, Stern MB. Diagnosis and epidemiology of Parkinson's disease Cns Spectrums. 3: 23-35.  1
1998 Fritze M, Stern MB, Wyatt PW. Laser-fabricated glass microlens arrays Optics Letters. 23: 141-143.  1
1997 Stern MB. Contemporary approaches to the pharmacotherapeutic management of Parkinson's disease: An overview Neurology. 49: S2-S9. PMID 9222270 DOI: 10.1212/WNL.49.1_Suppl_1.S2  1
1997 Stern MB. The changing standard of care in Parkinson's disease: Current concepts and controversies Neurology. 49: S1. PMID 9222269 DOI: 10.1212/WNL.49.1_SUPPL_1.S1  1
1997 Adler CH, Stern MB, Vernon G, Hurtig HI. Amantadine in advanced Parkinson's disease: Good use of an old drug [2] Journal of Neurology. 244: 336-337. PMID 9178162 DOI: 10.1007/s004150050098  1
1997 Stern MB, Freese A. Parkinson's disease: The case for novel treatment strategies Experimental Neurology. 144: 2-3. PMID 9126142 DOI: 10.1006/exnr.1996.6378  1
1997 Swartz MA, Munz M, Stern MB. Respiratory failure following stereotactic neurosurgery in a 53-year-old woman. Chest. 111: 1112-4. PMID 9106595  1
1997 Geis MW, Twichell JC, Efremow NN, Krohn KE, Stern MB, Lyszczarz TM. Diamond grit-based field emission cathodes Ieee Electron Device Letters. 18: 595-598. DOI: 10.1109/55.644082  1
1997 Stern MB. Pattern transfer for diffractive and refractive microoptics Microelectronic Engineering. 34: 299-319.  1
1997 Stern MB, Geis MW, Curtin JE. Nanochannel fabrication for chemical sensors Journal of Vacuum Science and Technology B: Microelectronics and Nanometer Structures. 15: 2887-2891.  1
1996 Freese A, Stern M, Kaplitt MG, O'Connor WM, Abbey MV, O'Connor MJ, During MJ. Prospects for gene therapy in Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 11: 469-88. PMID 8866488 DOI: 10.1002/Mds.870110502  1
1996 Hutton JT, Koller WC, Ahlskog JE, Pahwa R, Hurtig HI, Stern MB, Hiner BC, Lieberman A, Pfeiffer RF, Rodnitzky RL, Waters CH, Muenter MD, Adler CH, Morris JL. Multicenter, placebo-controlled trial of cabergoline taken once daily in the treatment of Parkinson's disease Neurology. 46: 1062-1065. PMID 8780092  1
1996 Stern MB. Binary optics: A VLSI-based microoptics technology Microelectronic Engineering. 32: 369-388. DOI: 10.1016/0167-9317(95)00369-X  1
1995 Colcher A, Stern MB. Therapy guided by symptoms for Parkinson's disease Contemporary Internal Medicine. 7: 39-47. PMID 10150345  1
1995 McDermott MP, Jankovic J, Carter J, Fahn S, Gauthier S, Goetz CG, Golbe LI, Koller W, Lang AE, Olanow CW. Factors predictive of the need for levodopa therapy in early, untreated Parkinson's disease. The Parkinson Study Group. Archives of Neurology. 52: 565-70. PMID 7763203 DOI: 10.1001/Archneur.1995.00540300037010  1
1995 Glosser G, Clark C, Freundlich B, Kliner-Krenzel L, Flaherty P, Stern M. A controlled investigation of current and premorbid personality: characteristics of Parkinson's disease patients. Movement Disorders : Official Journal of the Movement Disorder Society. 10: 201-6. PMID 7753062 DOI: 10.1002/Mds.870100211  1
1995 Doty RL, Bromley SM, Stern MB. Olfactory testing as an aid in the diagnosis of Parkinson's disease: development of optimal discrimination criteria. Neurodegeneration : a Journal For Neurodegenerative Disorders, Neuroprotection, and Neuroregeneration. 4: 93-7. PMID 7600189 DOI: 10.1006/neur.1995.0011  1
1994 Stern MB, Doty RL, Dotti M, Corcoran P, Crawford D, McKeown DA, Adler C, Gollomp S, Hurtig H. Olfactory function in Parkinson's disease subtypes. Neurology. 44: 266-8. PMID 8309571 DOI: 10.1212/Wnl.44.2.266  1
1994 Olanow CW, Fahn S, Muenter M, Klawans H, Hurtig H, Stern M, Shoulson I, Kurlan R, Grimes JD, Jankovic J. A multicenter double-blind placebo-controlled trial of pergolide as an adjunct to Sinemet in Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 9: 40-7. PMID 8139604 DOI: 10.1002/Mds.870090107  1
1994 Stern MB. The Franco-American book trade in the late eighteenth and early nineteenth centuries Publishing Research Quarterly. 10: 47-54. DOI: 10.1007/BF02680436  1
1994 Grossman M, Stern MB, Gollomp S, Vernon G, Hurtig HI. Verb Learning in Parkinson's Disease Neuropsychology. 8: 413-423.  1
1993 Doty RL, Golbe LI, McKeown DA, Stern MB, Lehrach CM, Crawford D. Olfactory testing differentiates between progressive supranuclear palsy and idiopathic Parkinson's disease. Neurology. 43: 962-5. PMID 8492953 DOI: 10.1212/Wnl.43.5.962  1
1993 Skolnick BE, Gur RC, Stern MB, Hurtig HI. Reliability of regional cerebral blood flow activation to cognitive tasks in elderly normal subjects Journal of Cerebral Blood Flow and Metabolism. 13: 448-453. PMID 8478403 DOI: 10.1038/Jcbfm.1993.59  1
1993 Stern MB. Parkinson's disease: Early diagnosis and management Journal of Family Practice. 36: 439-446. PMID 8463787  1
1993 Standaert DG, Stern MB. Update on the management of Parkinson's disease. The Medical Clinics of North America. 77: 169-83. PMID 8093493  1
1993 Auriacombe S, Grossman M, Carvell S, Gollomp S, Stern MB, Hurtig HI. Verbal fluency deficits in Parkinson's disease. Neuropsychology (Journal). 7: 182-192. DOI: 10.1037/0894-4105.7.2.182  1
1993 Grossman M, Carvell S, Peltzer L, Stern MB, Gollomp S, Hurtig HI. Visual Construction Impairments in Parkinson's Disease Neuropsychology. 7: 536-547.  1
1993 Auriacombe S, Grossman M, Carvell S, Gollomp S, Stern MB, Hurtig HI. Verbal Fluency Deficits in Parkinson's Disease Neuropsychology. 7: 182-192.  1
1993 Grossman M, Carvell S, Gollomp S, Stern MB, Reivich M, Morrison D, Alavi A, Hurtig HI. Cognitive and physiological substrates of impaired sentence processing in Parkinson's disease Journal of Cognitive Neuroscience. 5: 480-498.  1
1993 Stern MB. Joint symposium: Making way for international collaboratio Neurology. 43: S1-6-S1-7.  1
1993 Stern MB. Sinemet CR: Rationale and clinical experience Neurology. 43: S1-34-S1-35.  1
1992 Grossman M, Carvell S, Stern MB, Gollomp S, Hurtig HI. Sentence comprehension in Parkinson's disease: The role of attention and memory Brain and Language. 42: 347-384. PMID 1611464 DOI: 10.1016/0093-934X(92)90074-O  1
1992 Doty RL, Stern MB, Pfeiffer C, Gollomp SM, Hurtig HI. Bilateral olfactory dysfunction in early stage treated and untreated idiopathic Parkinson's disease. Journal of Neurology, Neurosurgery, and Psychiatry. 55: 138-42. PMID 1538221 DOI: 10.1136/Jnnp.55.2.138  1
1992 Grossman M, Crino P, Reivich M, Stern MB, Hurtig HI. Attention and sentence processing deficits in Parkinson's disease: the role of anterior cingulate cortex. Cerebral Cortex (New York, N.Y. : 1991). 2: 513-25. PMID 1477527 DOI: 10.1093/Cercor/2.6.513  1
1992 Stern MB. An Early Alcott Sensation Story: “Marion Earle; or, Only An Actress!” Nineteenth-Century Literature. 47: 91-98. DOI: 10.2307/2933766  1
1991 Stern MB. Head trauma as a risk factor for Parkinson's disease Movement Disorders. 6: 95-97. PMID 2057017  1
1991 Stern M, Dulaney E, Gruber SB, Golbe L, Bergen M, Hurtig H, Gollomp S, Stolley P. The Epidemiology of Parkinson's Disease: A Case-Control Study of Young-Onset and Old-Onset Patients Archives of Neurology. 48: 903-907. PMID 1953412 DOI: 10.1001/archneur.1991.00530210029018  1
1991 Grossman M, Carvell S, Gollomp S, Stern MB, Vernon G, Hurtig HI. Sentence comprehension and praxis deficits in parkinson’s disease Neurology. 41: 1620-1626. PMID 1922805 DOI: 10.1212/Wnl.41.10.1620  1
1991 Stern MB. Electroconvulsive therapy in untreated Parkinson's disease [1] Movement Disorders. 6: 265. PMID 1922134  1
1989 Stern MB. Early experience with percutaneous lateral discectomy Clinical Orthopaedics and Related Research. 50-55. PMID 2910618  1
1989 Stern MB, Braffman BH, Skolnick BE, Hurtig HI, Grossman RI. Magnetic resonance imaging in Parkinson’s disease and parkinsonian syndromes Neurology. 39: 1524-1526. PMID 2812334  1
1989 Adler CH, Stern MB, Brooks ML. Parkinsonism secondary to bilateral striatal fungal abscesses Movement Disorders. 4: 333-337. PMID 2811892  1
1989 Braffman BH, Grossman RI, Goldberg HI, Stern MB, Hurtig HI, Hackney DB, Bilaniuk LT, Zimmerman RA. MR imaging of Parkinson disease with spin-echo and gradient-echo sequences American Journal of Roentgenology. 152: 159-165. PMID 2783271  1
1989 Przystawski N, McGarry JJ, Stern MB, Edelman RD. Intratendinous ganglionic cyst Journal of Foot Surgery. 28: 244-248. PMID 2696747  1
1987 Stern MB, Angerman A. Comminuted intertrochanteric fractures treated with a Leinbach prosthesis Clinical Orthopaedics and Related Research. 75-80. PMID 3568499  1
1987 Stern MB, Brody E, Sowell B. InP electroluminescence as a tool to directly monitor carrier leakage in InGaAsP/InP buried heterostructure lasers Journal of Applied Physics. 62: 4920-4923. DOI: 10.1063/1.339002  1
1986 Stern MB, Gur RC, Saykin AJ, Hurtig HI. Dementia of Parkinson's disease and Alzheimer's disease. Is there is a difference? Journal of the American Geriatrics Society. 34: 475-478. PMID 3700936 DOI: 10.1111/J.1532-5415.1986.Tb03416.X  1
1986 Cohen DA, Savino PJ, Stern MB, Hurtig HI. Botulinum injection therapy for blepharospasm: A review and report of 75 patients Clinical Neuropharmacology. 9: 415-429. PMID 3533250  1
1986 Stern MB, Vernon GM, Gollomp SM, Hurtig HI. Low-dose, slow-increase bromocriptine in patients with progressive Parkinson's disease and complications of levodopa therapy Bulletin of Clinical Neurosciences. 52-56. PMID 3455244  1
1985 Hurtig HI, Stern MB. Thalamotomy for Parkinson's disease Journal of Neurosurgery. 62: 163-165. PMID 3964852  1
1985 Olshansky R, Fye DM, Manning J, Stern MB, Meland E, Powazinik W, Ulbricht LW, Lauer RB. HIGH POWER, HIGH SPEED EDGE-EMITTING LEDs FOR OPTICAL COMMUNICATION SYSTEMS . 1: 433-436.  1
1984 Stern MB. Phrenological analyses as collectible manuscripts Manuscripts (New York, N.Y.). 36: 101-121. PMID 11635361  1
1984 Stern MB. Emerson and phrenology Studies in the American Renaissance. 213-228. PMID 11618177  1
1984 Stern MB. The anterior interosseous nerve syndrome (the Kiloh-Nevin syndrome). Report and follow-up study of three cases Clinical Orthopaedics and Related Research. 223-227. PMID 6744722  1
1984 Stern MB, Craighead HG, Liao PF, Mankiewich PM. Fabrication of 20-nm structures in GaAs Applied Physics Letters. 45: 410-412. DOI: 10.1063/1.95239  1
1984 Glass AM, Liao PF, Johnson AM, Humphrey LM, Lemons R, Olson DH, Stern MB. Periodically structured amorphous silicon detectors with improved picosecond responsivity Applied Physics Letters. 44: 77-79. DOI: 10.1063/1.94558  1
1984 Stern MB, Harrison TR, Archer VD, Liao PF, Bean JC. Raman spectroscopic analysis of the CaF2Si heterostructure interface Solid State Communications. 51: 221-224. DOI: 10.1016/0038-1098(84)91000-7  1
1983 Liao PF, Glass AM, Johnson AN, Olson DH, Humphrey LM, Stern MB. Enhancement of optical detector response via microstructured electrodes Proceedings of Spie - the International Society For Optical Engineering. 439: 197-201. DOI: 10.1117/12.966097  1
1983 Stern MB, Liao PF. REACTIVE ION ETCHING OF GaAs AND InP USING SiCl//4 Journal of Vacuum Science and Technology B: Microelectronics and Nanometer Structures. 1: 1053-1055. DOI: 10.1116/1.582674  1
1983 Glass AM, Liao PF, Johnson AM, Humphrey LM, Olson DH, Stern MB, Lemons RA. GRATING COUPLED DETECTORS . 186.  1
1982 Liao PF, Heinz TF, Chen CK, Ricard D, Shen YR, Weitz DA, Garoff S, Alvarez MS, Chung JC, Wokaun A, Humphrey LM, Stern MB, Bechthold PS, Kettler U, Krasser W, et al. Surface spectroscopy Applied Physics B Photophysics and Laser Chemistry. 28: 229-232. DOI: 10.1007/BF00697849  1
1981 Stern MB, Kao YH. Regenerative feedback narrowing of Josephson radiation linewidth Physica B+C. 108: 995-996. DOI: 10.1016/0378-4363(81)90801-9  1
1981 Stern MB. The geographical ghost: a cautionary tale of a publishing non- event Map Collector. 14: 32-36.  1
Show low-probability matches.